Chapter 20: Pulmonary Circulation & Ventilation–Perfusion

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to The Deep Dive, the place where we take dense physiological concepts, use the best medical texts as our source material, cut through the noise, and deliver the absolute essentials you need to be truly well informed.

Today we are strapping in for a deep dive into the lungs blood supply, a system that fundamentally operates by a different set of rules than the rest of your body.

We're talking about the pulmonary circulation.

It's an area of physiology that's really defined by paradox.

I mean, your systemic circulation is built for high pressure, high resistance to precisely control where blood goes.

Right, based on what tissues need the most oxygen at that moment.

Exactly, but the pulmonary system has just one singular non -negotiable mission.

It has to handle 100 % of your body's entire cardiac output, but do so at the lowest possible pressure.

And while it's doing that, it has to constantly balance the supply of air with the supply of blood.

That's the whole game.

That balance this perfect dance between air, which we call ventilation or VA, and blood, which is perfusion or QGE.

That's the central life -sustaining concept of this entire deep dive.

We're talking about VAQ matching.

And when that delicate match fails, whether it's just in one small spot or across the whole lung, that's when you get into life -threatening clinical trouble very, very quickly.

Our analysis today is drawn from a really comprehensive chapter on pulmonary circulation and gas exchange.

We're going to focus on the pressure dynamics, the regulatory mechanisms,

and the critical consequences of imbalance.

So what's our mission for you, the listener?

The core goal is to understand not just the mechanics of this high -flow, low -pressure system, but how the body actively and passively manages blood delivery to where the air is, or crucially, how failure to do so results in crippling hypoxemia.

Which we see in everything from, say, a pulmonary embolus.

To chronic diseases like cystic fibrosis, the central concept.

So let's start at the very foundation, the unique characteristics that define this system.

Put simply, the pulmonary circulation is built for low resistance, low pressure, and incredibly high flow.

It basically defies the systemic model we usually carry around in our heads.

The difference is it's just astonishing when you see the numbers.

Okay, let's talk numbers then.

Frame this contrast for us.

All right, if you measure the systemic mean arterial pressure, your MAP, in the aorta, it's typically sitting around 93 millimeters of mercury.

The number we all know.

Right.

Now, if you take that same measurement in the pulmonary artery, pulmonary mean arterial pressure, it's generally only 15, one five.

Wow, that is almost a six -fold difference.

It completely reframes how you think about blood pressure.

In the systemic side, high pressure is needed to push blood everywhere.

To overcome resistance, push against gravity,

all of that.

So how does the manage to move the entire five liters of cardiac output every single minute with just 15 millimeters of mercury of pressure?

Because the resistance is proportionally tiny.

I mean, to calculate the pressure gradient that actually drives the flow, we look at the difference between that mean pulmonary artery pressure, the 15 millimillimillihg, and the pressure in the left atrium, which is around five millimillimillihg.

So the actual driving force is only 10.

Just 10 millimeters of mercury.

That tiny gradient is pushing the full five liters per minute.

So if you apply the basic physics of flow resistance equals the change in pressure divided by flow,

you calculate that the pulmonary vascular resistance or PVR is only about one -tenth of the systemic vascular resistance.

So the whole system is basically built on a foundation of near zero resistance.

It's like the blood is moving through a vast open multi -lane highway with no speed bumps.

That's a perfect analogy.

The vessels are structurally designed for this.

They're naturally dilated, very thin -walled, and highly compliant, which just means they stretch easily.

And that's different from systemic arterioles, which have a bit of a constant tone to them, right?

A constant partial constriction, yeah.

Pulmonary vessels are just relaxed.

This inherent low tone minimizes the energy the right side of the heart has to expend.

So let's dig into that structure.

Systemic vessels are muscular.

They're tough.

What makes the pulmonary structures so different?

Well, they follow the airways.

The pulmonary arteries branch right alongside the bronchi and bronchioles, but structurally they're different beasts entirely.

They have significantly less elastin and way less smooth muscle than their systemic counterparts.

Which makes them exceptionally fragile, but also very compliant.

Exactly.

This thinness is key to their function, but it also makes them highly vulnerable to external pressures.

And the exchange surface itself, the capillary bed, that's not just a regular tube network, is it?

No, it's a highly specialized structure.

It's designed to maximize the area where air meets blood.

The source describes the pulmonary capillary bed not as a network of tubes, but as a dense, thin sheet of capillaries, literally woven around the alveoli.

This sheet structure maximizes the surface area and minimizes the diffusion distance for gas exchange.

But I imagine that makes it very susceptible to pressure.

Extremely.

Because the walls are so thin and the sheet is so wide, the entire bed is incredibly vulnerable to mechanical pressures.

If the local alveolar pressure pushes too hard, that sheet can completely collapse and just shut down flow.

Now, beyond a gas exchange, we have to acknowledge the other roles the circulation plays.

It's not just a gas exchanger.

No, it's also a filter, a metabolic processing plant, and a blood reservoir.

Let's start with that filter function.

That sounds incredibly important.

It's maybe the most immediately protective function.

Since the pulmonary circulation receives 100 % of all venous blood returning from the body, it's the primary line of defense.

Protecting what?

The most sensitive circulations, your coronary arteries, your cerebral arteries, your renal arteries,

any small debris that gets into your systemic veins, a tiny blood clot, an air bubble from an injury, a fat globule from a broken bone, it gets trapped in the narrow pulmonary capillaries.

Before it can cause a stroke or a heart attack?

Precisely.

And the vessels themselves aren't just a passive knit, are they?

They're actively working to clear that debris.

Correct.

The endothelial cells that line the pulmonary vessels release what are called fibrinolytic substances.

These are chemicals that actively help dissolve trapped thrombi or clots.

So it's not just a blockade, it's an active clearing system.

Right.

It prevents what would otherwise be a major crisis if that clot ever reached the brain.

Okay, next function.

The metabolic one.

The lung as a chemical factory.

This function ensures certain hormones are either activated or destroyed on the spot.

And the classic example here is the renin angiotensin aldosterone system, or RAS,

the enzyme ACE, angiotensin converting enzyme.

The target of ACE inhibitors for blood pressure.

That's the one.

It's found in huge concentrations right on the surface of pulmonary capillary endothelial cells.

In one single rapid pass through the lung, ACE converts angiotensin in the first, which is pretty inactive.

Into angiotensin in the second.

A potent systemic vasoconstrictor.

And the efficiency is staggering.

Up to 80 % of angiotensin tonuses is converted in that single five -second journey through the lungs.

So the lung is actively manufacturing one of the most powerful blood pressure regulators in the

ensuring it's ready to go the moment it hits the systemic circulation.

It's a perfect example of rapid on -demand processing.

And this processing is highly selective.

It's like a molecular bouncer at a club deciding who gets to pass through and who gets broken down.

So which hormones are on the no -fly list and which ones get a pass?

The pulmonary endothelium rapidly inactivates powerful compounds like bradykinin, serotonin, and several prostaglandins.

But critically, it allows essential systemic hormones like epinephrine, histamine, and vasopressin to pass right through.

Totally unchanged.

Which makes sense.

You wouldn't want to neutralize your fight or flight response before it even starts.

Exactly.

It ensures that hormones needed for systemic defense or stress aren't prematurely taken out of commission.

Okay.

The third function, which is critical during a circulatory crisis, is the lung's role as a blood reservoir.

The entire pulmonary circulation holds about 500 milliliters of blood.

That's about 10 % of your body's total circulating volume.

And where is most of that held?

Interestingly, most of it, about 270 millilets, is held on the venous side.

The capillaries themselves hold a volume that's roughly equal to the stroke volume of the right ventricle,

about 80 millilets.

And why is this reservoir so important?

In a crisis, like a severe hemorrhagic shock where you're losing blood volume fast, the body can mobilize this stored blood.

It can push it out of the pulmonary veins and back into the systemic circulation.

To help prop up cardiac output and blood pressure.

Exactly.

It's a temporary fix, a buffer that helps maintain critical systemic pressure until the systemic losses can be corrected.

Okay.

Finally, before we jump into how PVR is regulated, we have to make a key distinction.

There's the main pulmonary circulation, and then there's a smaller parallel system.

The bronchial circulation.

Right.

What does it do?

The bronchial circulation exists primarily to nourish the walls of conducting airways themselves, the bronchi and bronchioles, and the supporting lung structures.

It does not participate in gas exchange at the alveoli.

And functionally, it's basically part of the systemic circulation.

Correct.

It operates at high aortic level pressures and has a high vascular resistance.

So its total flow is tiny, usually only one to two percent of the cardiac output.

So it's structurally and functionally the complete opposite of the pulmonary circulation?

Precisely.

And the key difference from a recovery standpoint is that the bronchial circulation is the only part of the adult lung that's capable of angiogenesis.

Forming new vessels.

Yes.

So if the main pulmonary artery is blocked, say by a large plot, the bronchial vessels can sometimes develop collateral circulation around that blockage, which is critical for keeping the lung tissue alive.

And it's also important to remember that some of that bronchial venous blood drainage contributes to the normal physiological shunt we all have.

That's right.

About half of it returns to the right atrium, but the other half drains directly into the pulmonary veins, mixing a little bit of unoxygenated blood with the freshly oxygenated blood from the lungs.

Okay.

So that sets the stage.

Now let's get into the dynamics of how this low resistance is regulated.

We've established that the pulmonary circulation is inherently low resistance, but that resistance isn't static.

It's actively regulated, both passively and actively.

Let's unpack that core physiological paradox again.

PBR is inversely related to cardiac output.

In the rest of the body, if you run a marathon,

resistance often has to rise to direct blood flow.

But in the lungs, when flow increases, say four or five times during vigorous exercise,

the pulmonary vascular resistance actually falls.

And that inverse relationship is probably the system's most crucial protective feature.

It absolutely is.

It means the system can accommodate these massive increases in flow up to 25 liters per minute without the pulmonary pressure going through the roof.

Which protects the right ventricle from failing under the load.

And it prevents the pressure from rising so high that it causes fluid to leak out into the lungs, which is pulmonary edema.

And this accommodation happens through two immediate passive local mechanisms.

The first one is capillary recruitment.

Think of the lungs as being constantly ready to handle more traffic.

Under normal resting conditions, especially up in the top, the apex of the lung where gravity means pressure is lowest.

Many of the pulmonary capillaries are partially or even completely closed.

They're just not being perfused.

Okay, so they're just waiting in the wings.

Exactly.

When blood flow increases and the pulmonary arterial pressure rises,

the sheer force of that pressure forces these previously closed vessels to open up.

It recruits them.

And that dramatically increases the total cross -sectional area of the entire capillary bed.

More lanes on the highway.

By opening more pathways, you immediately lower the overall resistance.

It's a very simple, elegant, mechanical solution.

So recruitment is about maximizing the available lanes.

The second mechanism, capillary distension, is about widening the lanes that are already open.

You got it.

Because the pulmonary vessels are so thin -walled and highly compliant, that increased pressure physically stretches and widens the vessels that are already perfused.

Which contributes more to the drop in PVR.

Recruitment provides the bulk of the initial drop, while distension really kicks in as flow and pressure continue to rise.

They work together to keep resistance low, which also maintains adequate contact time for gas exchange, even as the blood is moving faster.

Okay, let's move to the second major passive regulator,

the physical state of the lung or lung volume.

This relationship is complex.

It results in that distinct U -shaped curve we see in textbooks.

Right, the one where PVR is lowest functional residual capacity, or FRC.

This is a classic example of competing mechanical forces.

It is.

And to understand the U -shape, you have to split the lung vessels into two groups.

The alveolar vessels and the extra alveolar vessels.

They're connected in series, so the total resistance is just the sum of their individual resistances.

Okay, so let's start at one end of the U.

Why does resistance increase at high lung volume when you're near total lung capacity?

Imagine your lung tissue expanding like a gigantic balloon.

At high lung volumes, the air sacs, the alveoli are maximally stretched.

These big expanded alveoli physically stretch and squeeze the delicate alveolar vessels, the capillaries that are woven around them.

So they're being squashed flat.

That compression dramatically increases the resistance of the alveolar vessels.

At the same time,

the negative pressure in the chest cavity is pulling open the larger extra alveolar vessels, the arteries and veins, actually lowering their resistance.

But because they're in series, that massive increase in resistance from the compressed capillaries just overwhelms the decrease from the larger vessels.

And the net result is high total PVR, precisely.

So now let's look at the other extreme.

Low lung volumes.

Down near residual volume.

Resistance increases again, completing the U.

Why?

At low volumes, the air sacs shrink, which releases the pressure on the alveolar capillaries.

So their resistance falls.

Okay, that makes sense.

But now the surrounding pressures change.

Because the overall lung volume is low, the lung tissue isn't recoiling as much, and the pressure in the chest can become less negative or even positive.

This causes the larger, more compliant, extra alveolar vessels to get compressed and kinked.

Ah, so now the other set of vessels is getting squeezed.

Right.

The rise in resistance from these compressed extra alveolar vessels is what dominates at low lung volume, causing the total PVR to rise again.

The optimal sweet spot, the very bottom of that U -curve, is FRC.

That's where the balance between these two opposing forces results in the minimum total resistance.

That makes the U -curve far more intuitive.

Okay, let's shift to active regulation.

This brings us back to another physiological paradox.

Hypoxia -induced pulmonary vasoconstriction.

This is a single most important active mechanism for regulating blood flow in the lungs.

And it is the direct opposite of what happens in the systemic circulation.

Right.

When your muscles are low on oxygen, their blood vessels dilate to bring in more blood.

But when pulmonary vessels sense low alveolar oxygen, they constrict.

Why on earth would they constrict?

If oxygen is low, why not send more blood?

Because the body's priority here is efficiency, not just delivery.

If an air sac has low oxygen, it means that air sac is poorly ventilated.

It can't do its job of exchanging gas.

So sending blood there is a waste of cardiac output.

It's a total waste.

Constriction is a beneficial active response that senses this regional problem and diverts blood away from that poorly ventilated hypoxic region.

It shunts it toward healthy, well -ventilated areas where gas exchange can actually happen.

So we see two very different outcomes depending on the scale of the hypoxia.

Regional is good, but generalized is bad.

Very bad.

Regional hypoxia say, A small area of the lung is blocked by mucus causes localized phasoconstriction.

This response is a success.

It improves the overall VHH matching of the lung and has basically no effect on the overall pulmonary arterial pressure.

It's a genius autoregulation mechanism.

But when the hypoxia is generalized, affecting the entire lung, the system runs into big trouble.

Generalized hypoxia happens in severe lung diseases like COPD or when people go to high altitudes.

When the entire lung constricts at the same time, the total PVR just skyrockets.

Leading to dangerously high pressure in the pulmonary circuit.

Which is pulmonary hypertension.

This mechanism also plays a beautiful necessary role in fetal circulation.

It illustrates its power to shut down the entire lung when needed.

Absolutely.

Before birth, the alveoli are filled with fluid so they get no oxygen.

Generalized hypoxia reigns supreme.

This keeps the PVR extremely high.

Which is essential.

Because it shunts most of the blood away from the non -functional lungs and through the fetal bypasses, the form an ovale and the ductus arteriosus out into the systemic circulation.

And then the baby takes its first breath.

And that sudden flood of oxygen into the alveoli causes an immediate massive relaxation of the smooth muscle and dilation of the vessels.

PVR plummets by 80 to 90 percent.

And that sharp drop in resistance is what causes those fetal shunts to close.

Routing all the cardiac output through the now functional lungs,

it's an incredible physiological transformation that happens in just a few seconds.

Moving from flow control to fluid balance.

The central goal of this entire system is to keep the alveolus dry.

Gas exchange needs air, not fluid.

The forces at play here are the classic Starling forces.

But with two unique pulmonary twists.

That's right.

We're still relying on the balance of hydrostatic pressure, which pushes fluid out of the capillary and colloid osmotic pressure, which pulls fluid back in.

But the lungs add two critical mechanical pressures that affect the interstitial space where the fluid exchange actually happens.

Alveolar surface tension and alveolar pressure.

Let's define their influence.

Alveolar surface tension is that force that tries to collapse the alveoli.

But here it also plays a role in fluid movement.

It does.

Because the fluid lining the alveolus is being pulled inward by surface tension, that inward pull tends to lower the pressure in the interstitial space right next to the alveolus.

Okay, so it creates a bit of a suction effect.

Effectively, yes.

It draws fluid out of the capillaries, promoting a continuous filtration into the interstitial space.

And the alveolar pressure counters that.

The physical pressure of the air inside the alveolus presses on all the surrounding structures, and that tends to compress the interstitial space.

This compression raises the interstitial pressure, which in turn opposes filtration.

It's a constant local tug of war.

Crucially, though, the systemic low pressure design of the whole circuit is our primary defense against fluid leakage.

It is the ultimate safeguard.

The normal pulmonary capillary hydrostatic pressure is exceptionally low, only 8 to 10 millimeters of mercury.

And that's dramatically lower than the plasma colloid osmotic pressure.

Which averages around 25 millimeter Hg.

So if you just look at those two forces, there's a very strong pressure gradient that favors the net absorption of fluid back into the capillaries.

This powerful absorption potential is the main reason our alveoli stay dry.

But wait, if the pressure balance so strongly favors absorption, why do we need a lymphatic system at all?

Why isn't all the fluid just perpetually sucked back into the blood?

That's a great question.

It gets to the nuance of the system.

While the hydrostatic pressure is low, that effect of alveolar surface tension, that little bit of suction, it partially offsets the absorption advantage.

This means there is still a small continuous flux of fluid leaking out of the capillaries into the interstitial space.

It's small, about half a milliliter per minute, but it's persistent and it has to be managed.

And that's where the extensive lymphatic system steps in as the drainage crew.

The lymphatics are the crucial failsafe.

They're strategically located in the spaces around the vessels and bronchioles, and they're constantly draining the fluid that moves into the interstitium.

The very movement of your lungs during breathing helps propel this fluid away, keeping the gas exchange surfaces clear.

Pulmonary edema, then, is what happens when that filtration overwhelms lymphatic drainage.

And clinically, we separate this into two distinct types.

First, and most common, is cardiogenic edema.

This is fundamentally a plumbing and pressure failure, almost always caused by an increase in capillary hydrostatic pressure.

So a problem with the heart?

Usually the left heart.

If the left heart fails from a heart attack or long -term hypertension or a bad valve blood backs up into the pulmonary veins and capillaries, this raises the pressure from 10 milliliter per minute up towards 25.

Once that hydrostatic pressure gets close to or exceeds the plasma colloid osmotic pressure, the dam breaks, filtration skyrockets, and you get rapid edema.

And cardiogenic edema can also be caused by a drop in the opposing pressure, right, if the osmotic pressure falls.

Absolutely.

If your plasma colloid osmotic pressure drops, say, from severe malnutrition or liver disease where you're not making enough protein,

the natural pull holding fluid in the capillaries diminishes.

This can also tip the balance toward filtration, even if the hydrostatic pressure is normal.

The second type is non -cardiogenic edema, which sounds like a much more aggressive problem rooted in structural damage.

It is.

This results from direct lung injury trauma, a severe infection, inhaling something toxic.

The injury increases the permeability of the alveolar capillary membrane itself.

The barrier becomes leaky.

Which is critical because it allows large plasma proteins, which are normally held inside the capillary, to leak out.

And once those proteins get into the interstitial space, they bring water with them, they raise the interstitial colloid osmotic pressure, which wipes out the gradient that normally favors absorption.

Now you have a massive osmotic pull out of the capillaries.

And that's much harder to treat, because you're dealing with a leaky barrier, not just high pressure.

Exactly.

The resulting edema is disastrous for gas exchange.

The fluid forms a barrier, making the lungs stiff, increasing the work of breathing, and leading to severe hypoxemia.

This fragility, this whole system being defined by low pressure, is perfectly illustrated by the tragic clinical distinction between freshwater and saltwater drowning.

It really shows how quickly the balance can be destroyed.

So let's start with freshwater.

It's hypotonic, meaning it has a lower salt concentration than our blood.

Because the capillary hydrostatic pressure is so low, and the blood's osmotic pull is high, the hypotonic water is rapidly pulled across the thin alveolar membrane and into the pulmonary circulation.

It gets absorbed into the bloodstream.

Right.

This sudden influx of pure water causes rapid plasma dilution, and catastrophically causes red blood cells to burst homolysis.

Death in freshwater drowning is often due to the resulting acute electrolyte imbalances.

A spike in potassium, a drop in sodium, which immediately disrupts the heart's electrical rhythm, leading to ventricular fibrillation.

It's a circulatory, electrolyte -driven failure.

Now contrast that with saltwater drowning.

Seawater is hypertonic.

It's very salty.

When hypertonic saltwater is aspirated, it immediately exerts a massive osmotic pull in the other direction.

It draws fluid out of the pulmonary capillaries and into the alveoli, causing rapid massive pulmonary edema.

Exactly.

The patient's circulation isn't immediately compromised by electrolytes, but their alveoli quickly fill with fluid.

The cause of death is overwhelming asphyxia, a respiratory failure.

It's just a stark reminder of how delicate this balance is.

We have to now integrate gravity into this equation because the compliant nature of these vessels makes them extraordinarily sensitive to hydrostatic pressure, changes across the vertical height of the lung.

In an upright person, blood flow distribution is extremely uneven.

Flow decreases almost linearly as you move from the base, the bottom to the apex, the top of the lungs.

And that's just from the weight of the column of blood.

It is.

The physical height difference in arterial pressure between the base and apex is significant, about 22 millimeters of mercury.

Since the heart sits about midway, the apex pressure is about 11 millimiliK less than the mean, and the base pressure is about 11 millimiliHT more.

And this gravitational pressure increase at the base means those capillaries are distended and recruited, maximizing flow while the apex gets a mere trickle.

That's the baseline state.

This uneven distribution is why the lung is physiologically divided into the three west zones based on which pressure arterial, alveolar, or venous is dominant in that region.

Let's define zone one at the very top, the non -perfused apex.

The pressure relationship here is alveolar pressure is greater than arterial, which is greater than venous.

Or PAPAV, the alveolar air sac pressure literally squeezes the capillary shut, resulting in no blood flow.

For a healthy resting person,

zone one is usually very small or non -existent.

But if zone one is created, it has a major clinical consequence.

Increase alveolar dead space.

You're wasting air.

Exactly.

You are still ventilating that part of the lung, but the air is wasted because no gas exchange can occur.

Clinically, you can create zone one by raising the alveolar pressure, like with high positive pressure ventilation, or by lowering the arterial pressure, like during a severe hemorrhage.

Moving down, we hit zone two in the middle lung field.

This is the region of the waterfall effect.

Right.

Here, the arterial pressure is sufficient to push blood into the capillary.

But the alveolar pressure is still greater than the downstream venous pressure, PIPV.

Which means the venous pressure has absolutely no influence on flow.

None.

It's like a waterfall.

Flow is determined by the difference between the inflow pressure, PAW, and the external pressure surrounding the capillary, which is PA.

The flow only increases as you move down through zone two, because PAW is rising due to gravity, widening that PAW minus PA gradient.

And finally, zone three, the gravity -dependent base of the lung, where flow is maximal.

In zone three, both the arterial and venous pressures exceed the alveolar pressure.

PAW -PV -PA, alveolar pressure is no longer a factor.

Flow here is determined by the normal arterial -venous pressure difference.

The reason flow is so high is because the capillaries are maximally distended and fully recruited.

And it's important to remember that when we exercise, the increase in pulmonary arterial pressure causes widespread recruitment and distension, which increases flow in zones two and one, evening out the distribution.

It does.

It makes a lung much more homogeneous in terms of perfusion.

Understanding those zones is crucial because they translate directly into variations in ratio of air to blood, the V -acuge ratio.

And efficient gas exchange requires a perfect match.

Let's define the ideal average ratio first.

For a healthy resting person, we have about four liters per minute of alveolar ventilation, VJ.

And about five liters per minute of perfusion, huge.

Which gives us an overall ideal VJ ratio of 0 .8.

But due to gravity, that 0 .8 is just an average.

Regionally, the match is imperfect.

While both ventilation and perfusion increase as you go down the lung, perfusion is far more sensitive to gravity than ventilation is.

So the change is disproportionate.

Very.

Perfusion changes by about five times from apex to base, while ventilation only changes by about two times.

This is what causes the mismatch.

Okay, let's analyze the apex, where the ratio is high.

The apex, existing mostly in the upper part of zone two, has a high VJ -acuge ratio, sometimes three or even higher.

This means the area is over -ventilated relative to the blood flow it receives.

Think of it as a huge air supply reaching a tiny little road.

And the physiological consequence is that the blood leaving this region is maximally oxygenated.

Almost identical to the air in the alveolus itself.

The blood leaving here has a very high PO2, maybe 130 milliliter Hg, and very low passio -2, around 28 milliliter Hg.

And clinically, this high oxygen, well ventilated but under perfused environment, is why infections like tuberculosis historically tend to localize at the long apex.

The bacteria thrive in that high oxygen tension.

Now let's look at the base, zone three, where the ratio is low.

The base has a low VJ ratio, often dipping down to .6.

Here, perfusion is proportionately greater than ventilation.

The blood flow is massive, but the air supply is slightly insufficient to handle that huge volume.

It's a tiny air supply trying to serve a massive six -lane highway.

So the blood leaves the base slightly compromised.

But nicely.

The blood leaving this region has a slightly low PO2, say 88 milliliter Hg, and a slightly high passio -2, maybe 42 milliliter Hg.

Since the majority of your cardiac output passes through the base, the mixing of this slightly deoxygenated blood with the highly oxygenated blood from the apex is what gives you your normal systemic arterial PO2 of around 100.

The crucial takeaway here for you is that any pathological deviation from that ideal ratio of .8 high or low impairs gas exchange, and lowers your overall systemic arterial oxygen level.

And this leads us directly to the concepts of wasted air and wasted blood, which are essential for understanding respiratory pathology.

Regions with a very high V -chacs ratio, where air supply exceeds blood supply, lead to wasted air.

The total wasted air is called physiologic dead space.

This includes the normal anatomic dead space, your conducting airways, plus any alveolar dead space, like those collapsed camelaries in zone 1.

Ventilated, but not perfused.

Conversely, regions with a very low VIH ratio, where blood flow exceeds air supply, result in wasted blood.

Or what we call venous admixture.

The total wasted blood is the physiologic shunt.

This is blood that returns to the systemic circulation without being fully oxygenated.

It's like mixing deoxygenated venous blood with your oxygenated arterial blood.

Let's break down that physiologic shunt, the wasted blood, because it is a major cause of hypoxemia and disease.

It has two components.

The first is the anatomic shunt.

This is blood that bypasses the gas exchange surface entirely for structural reasons.

The most common natural example is that deoxygenated bronchial venous blood that drains directly into the pulmonary veins.

And pathologically, this would include things like holes in the heart.

Great.

Congenital right to left heart defects.

In a healthy person,

that normal bronchial return accounts for about half of our minor baseline venous admixture.

The second component is the low regional V -SheQ.

This accounts for the other 50 % in a healthy individual, primarily from the gravity -dependent lung bases.

But this component explodes in pathological conditions like pneumonia or asthma, where airway obstruction means ventilation is drastically reduced in areas that are still getting blood flow.

So the total physiologic shunt in a healthy person is minor.

Very.

Maybe 1 % to 2 % of cardiac output.

But in severe respiratory distress, it can climb to 50 % or more, which is catastrophic for oxygenation.

To illustrate how crucial V -SheQ matching is, let's look at one of the most critical and common disorders.

Pulmonary embolism or P .E.?

A P .E.

occurs when a plug, usually a piece of a blood clot, from the leg veins lodges in a branch of the pulmonary artery.

And this immediately and profoundly impacts the V -SheQ's ratio in that part of the lung.

The blockage means blood flow, QC suddenly stops.

But ventilation, V -SheQ, to that air sac often continues.

The ratio approaches infinity.

The region becomes entirely non -perfused, immediately converting that lung unit into pure physiologic dead space.

Wasted air.

Which is why the patient feels so suddenly short of breath.

They're breathing, but a portion of that breath is doing nothing.

They're effectively losing lung capacity.

And the clot itself causes secondary damage.

The thrombi release vasoactive and bronchoconstrictive mediators.

So the airways around the clot start to constrict.

Further complicating the breathing pattern.

And they cause endothelial damage, leading to local edema and potential collapse of the alveoli.

If the embolus is large enough, the lung tissue beyond the blockage can actually die.

A pulmonary infarction.

Right.

And the diagnosis ties right back into this physiology.

A ventilation perfusion scan.

A VQ scan is key.

How does that work?

The perfusion part involves injecting labeled albumin aggregates into the veins.

They travel to the lungs and lodge in the small arteries.

Regions with an embolus will show a clear cold spot, no tracer uptake.

Proving the area is ventilated, but not perfused.

Confirming that massive V -SheQ mismatch.

We previously discussed how generalized hypoxia leads to pulmonary hypertension.

Let's expand on the chronic effects.

The vascular remodeling we see in disorders like COPD.

When generalized hypoxia persists, like with chronic high altitude exposure or severe emphysema,

the body's localized defense mechanism, vasoconstriction, becomes a systemic pathology.

That sustained high pressure causes major, often irreversible structural changes in the pulmonary arteries.

We see increased wall thickness,

hypertrophy, and hyperplasia of the smooth muscle cells.

The lumens of the arteries narrow significantly.

Pathologically, muscle tissue even extends into the very peripheral vessels that should be thin and unmuscled.

And all of these changes fundamentally and permanently increase the PVR.

Making the pulmonary hypertension severe, this increased resistance then directly damages the right side of the heart.

The right ventricle, which is thin -walled and designed to pump against low pressure, must continuously work harder.

It leads to right heart hypertrophy and eventually failure.

A condition we call core pulmonal.

This is a primary driver of mortality in patients with advanced COPD.

It's a devastating feedback loop.

The body's protective mechanism, when applied globally and chronically, ends up destroying the very pump it was meant to protect.

Finally, let's use a comprehensive case study cystic fibrosis to see how a single molecular defect can systematically dismantle this whole VQ matching system.

The case of a patient like Jack illustrates this progression perfectly.

CF is the most common inherited disorder in the US.

Rooted in a defective gene for the cystic fibrosis transmembrane conductance regulator protein, or CFTR.

Which is a chloride ion channel?

Right.

Found in exocrine glands throughout the body.

The core problem is faulty chloride and water movement across membranes.

And what does that mean for the lungs?

In the lungs, dysfunctional CFTR means the mucus lining the airways can't be properly hydrated.

The result is thick, sticky, dehydrated mucus that becomes nearly impossible to clear.

It just sits in the small airways, causing chronic obstruction.

And this chronic airway obstruction is the direct cause of the VQ mismatch?

Absolutely.

The thick mucus plugs severely and chronically lower the regional V -choose ratio in the affected lung segments.

These areas become drastically underventilated relative to their blood flow, leading to increased venous admixture and systemic hypoxemia.

And the stagnant ucus is a breeding ground for infection.

A perfect breeding ground for chronic antibiotic -resistant infections.

This leads to a vicious cycle of inflammation, infection, and irreversible damage, which further compounds the VQ problem.

And this eventually leads to the chronic generalized hypoxia we just discussed.

The entire lung vasculature begins to constrict and remodel, putting massive strain on the right heart, driving the patient toward eventual right heart failure.

It's a systemic problem with catastrophic pulmonary consequences.

But the clinical field has seen massive advancements recently, which directly target that faulty CFTR protein.

That's the cutting -edge insight.

Treatments now include what are called CFTR modulators.

These drugs dramatically improve the function of the faulty protein.

By improving the fundamental flow of chloride ions, they help rehydrate the mucus,

improve airway clearance, and reduce chronic infection.

So they're directly fighting the VQ mismatch at its molecular source.

Which is offering a massive leap forward in prognosis.

It's an incredible story.

This whole deep dive has been a masterclass in complexity, showing the lungs aren't just passive bellows.

They are a dynamically regulated, fragile masterpiece of hydraulic engineering.

It's a system of trade -offs, really, where maximum efficiency, that low -pressure, high -surface area is prioritized, even at the cost of structural stability.

So let's quickly recap the three most important physiological principles that define the pulmonary system for you.

First, the pulmonary circulation is defined by its low -pressure, low -resistance dynamics, where PVR decreases when cardiac output increases.

Primarily via capillary recruitment and distension.

This is the crucial protective mechanism against right heart strain and pulmonary edema.

Second, the major active regulator of flow is regional alveolar hypoxia, which uniquely causes pulmonary vasoconstruction.

This acts as an immediate local defense, shunting blood away from poorly scintillated regions to optimize gas exchange.

But when this response is triggered globally, it becomes pathological, driving pulmonary hypertension.

And third, due to gravity, there is an unavoidable linear mismatch of ventilation and perfusion from the apex, with its high ratio and wasted air to the base, with its low ratio and wasted blood.

And any pathological deviation from that ideal ratio of 0 .8.

Severely impairs gas exchange and creates a large physiologic shunt, lowering the oxygen tension in your systemic arterial blood.

This functional architecture where the lung must always maintain a hydrostatic pressure that's significantly lower than the plasma osmotic pressure just to keep the alveoli dry is essential for life.

And yet, as we saw with the drowning outcomes, it makes the body incredibly vulnerable to sudden shifts in fluid balance, whether from heart failure or water aspiration.

Which brings us to our final provocative thought for you to consider.

Given that this low pulmonary capillary hydrostatic pressure is the primary mechanism preventing continuous fluid leakage,

how does the body's design rapidly rebalance this fine line during periods of extreme physiological stress -like prolonged positive pressure ventilation or explosive inflammatory crises, where both pressures are rapidly changing and the integrity of the barrier itself is compromised?

It's a dynamic balancing act that really defines survival in respiratory medicine.

A system that manages low pressure, high flow, and gravity all at once.

Thank you for joining us for this deep dive into pulmonary circulation and VHA -cute matching.

We'll see you next time.